News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Petros Grivas: Best of ASCO in Seattle
Petros Grivas/X
Jun 15, 2025, 18:55

Petros Grivas: Best of ASCO in Seattle

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance, shared a post on X:

“Fantastic day 1 in Binaytara. Best of ASCO in Seattle with great speakers, discussions, Q and A: Interactive and fun, also with Greek mythology.”

Petros Grivas

Later, he shared another post featuring DAY 2 in Binaytara:

“Phenomenal 2nd day Binaytara. Best of ASCO with interactions with colleagues/friends in broader community!
Stellar speakers and team based learning! “

Petros Grivas

More posts featuring Petros Grivas on OncoDaily.

Binaytara cancer OncoDaily Oncology Petros Grivas University of Washington and Seattle Cancer Care Alliance
Special Coverage
Oncolibrary
Jul 7, 2025, 16:44
Botensilimab and Balstilimab Achieves 21-Month Survival in mCRC and FDA Endorsement for Global Phase 3 Trial
Blog
Jul 7, 2025, 16:07
IV Research Day Dedicated to Clinical Research Will Be Held on October 6 - European Institute of Oncology
Oncolibrary
Jul 7, 2025, 15:48
Why Colonoscopy Is the Gold Standard in Early Detection of Colon Cancer Screening
Science
Jul 7, 2025, 15:44
Giuseppe Minniti: Happy to Introduce a New Proof of Concept - Strategic Radiotherapy
Oncolibrary
Jul 7, 2025, 15:12
MASCC 2025 Highlights: Long-Term Outcomes from RCT of Mepitel Film in Breast Cancer Radiotherapy
Blog
Jul 7, 2025, 15:05
Meet Josee, an Incredible Participant in the Training of Trainers Workshop on Palliative Care - ACREOL Global
Oncolibrary
Jul 7, 2025, 14:52
Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update
Science
Jul 7, 2025, 14:51
Reirradiation Techniques, Survival Outcomes, Dose, and Toxicity in Gynecological Cancers by Dina Najjari et al.
Blog
Jul 7, 2025, 14:51
First Annual Sam-a-palooza Raised $8,000 Through Donations and Registrations - Cholangiocarcinoma Foundation
Science
Jul 7, 2025, 14:34
Fabio Girardi: The Omission of Anthracyclines for the Adjuvant Treatment of Women with TNBC
Blog
Jul 7, 2025, 14:21
Enduring Partnerships among Cancer Survivors, Advocates, and Scientists with the AACR Scientist-Survivor Program
Science
Jul 7, 2025, 14:13
Hung Trinh: First In-Depth Comparative Biomonitoring of CAR-T in Multiple Myeloma Patients